Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
NCT00268970
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
Satraplatin in combination with Paclitaxel
Sponsor
Agennix